Tony Michael Argenbright

Array ( [id] => 14196581 [patent_doc_number] => 10265376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-23 [patent_title] => Use of chelating agent and peptide antimicrobial compounds [patent_app_type] => utility [patent_app_number] => 13/879169 [patent_app_country] => US [patent_app_date] => 2011-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5120 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9350335 [patent_doc_number] => 08669226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-11 [patent_title] => 'Antimicrobial compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/267977 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 10991 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13267977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363681 [patent_doc_number] => 08252745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Methods for treatment of headaches by administration of oxytocin' [patent_app_type] => utility [patent_app_number] => 13/269527 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 17253 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13269527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9875305 [patent_doc_number] => 08962572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Bortezomib formulations' [patent_app_type] => utility [patent_app_number] => 13/252421 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7455 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13252421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818761 [patent_doc_number] => 20120065381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'PROTEIN PURIFICATION' [patent_app_type] => utility [patent_app_number] => 13/252952 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14324 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065381.pdf [firstpage_image] =>[orig_patent_app_number] => 13252952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653052 [patent_doc_number] => 08372800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Albumin-free factor VIII formulations' [patent_app_type] => utility [patent_app_number] => 13/250789 [patent_app_country] => US [patent_app_date] => 2011-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7537 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13250789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11574650 [patent_doc_number] => 09629890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Peptides containing tryptophan' [patent_app_type] => utility [patent_app_number] => 13/877561 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3359 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7716867 [patent_doc_number] => 20120007022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'Control of Cyanate in Aqueous Urea Solutions by non-1,2-Ethylene Diamine like Compounds for the Protection of Protein/Peptide Carbamylation' [patent_app_type] => utility [patent_app_number] => 13/240482 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5433 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20120007022.pdf [firstpage_image] =>[orig_patent_app_number] => 13240482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9435967 [patent_doc_number] => 20140113874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'Modified Compstatin With Improved Stability And Binding Properties' [patent_app_type] => utility [patent_app_number] => 13/825775 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7113 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086549 [patent_doc_number] => 08557978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 13/238391 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17169 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13238391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9082150 [patent_doc_number] => 20130267680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'TOTAL CHEMICAL SYNTHESIS OF UBIQUITIN, UBIQUITIN MUTANTS AND DERIVATIVES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/823728 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13732 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427351 [patent_doc_number] => 08703425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Biomarker for gastric cancer' [patent_app_type] => utility [patent_app_number] => 13/230670 [patent_app_country] => US [patent_app_date] => 2011-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20243 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13230670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9004354 [patent_doc_number] => 20130225479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'Methods and Compositions for Treating Inflammation' [patent_app_type] => utility [patent_app_number] => 13/818620 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 21545 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9016310 [patent_doc_number] => 20130231274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'FUSION PROTEIN HAVING TRANSCRIPTION FACTOR TRANSACTIVATION-REGULATING DOMAIN AND PROTEIN TRANSDUCTION DOMAIN, AND TRANSCRIPTION FACTOR FUNCTION INHIBITOR COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/818062 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7731 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657486 [patent_doc_number] => 20110306755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'HUMAN PLACENTAL COLLAGEN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/212661 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 33096 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306755.pdf [firstpage_image] =>[orig_patent_app_number] => 13212661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12171059 [patent_doc_number] => 09889176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-13 [patent_title] => 'Treating renal and liver dysfunction with TLR4 antagonists' [patent_app_type] => utility [patent_app_number] => 13/817374 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 25 [patent_no_of_words] => 15832 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043315 [patent_doc_number] => 20120071397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'Methods for Hematopoietic Stem Cell Transplantation' [patent_app_type] => utility [patent_app_number] => 13/206690 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3345 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071397.pdf [firstpage_image] =>[orig_patent_app_number] => 13206690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10032669 [patent_doc_number] => 09073975 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion' [patent_app_type] => utility [patent_app_number] => 13/818444 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35255 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8830265 [patent_doc_number] => 20130131310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO' [patent_app_type] => utility [patent_app_number] => 13/812149 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 39335 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823722 [patent_doc_number] => 08933207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Drug-ligand conjugates, synthesis thereof, and intermediates thereto' [patent_app_type] => utility [patent_app_number] => 13/811745 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 50 [patent_no_of_words] => 47161 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811745 [rel_patent_id] =>[rel_patent_doc_number] =>)